Piclozotan Hydrochloride Hydrate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePiclozotan Hydrochloride Hydrate
Drug Alias Namepiclozotanum吡氯佐坦盐酸盐水合物piclozotanSUN-N4057SUN-4057
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsStrokeParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsStrokeParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A